KLK3 and cancer: The extent of the disease (staging) is determined based on TNM (classification system of malignant tumours), histology including the Gleason Score, the initial level of increased PSA values and the dynamics of changes in the PSA level, grouping the patients into the following risk categories according to Table 1 [14,15]: